There are several factors making an impact on spine research and innovation today, with some posing challenges while others offer opportunities for growth and development.
The Latest
Fardad Mobin, MD, is a board-certified, fellowship-trained neurosurgeon who treats spinal disorders. He specializes in minimally invasive spine surgery and aims to provide strategically conceived approaches to the spinal pathology to minimize collateral normal tissue damage.
Todd Helton, veteran first baseman for the Colorado Rockies, will undergo season-ending hip surgery, according to an MLB report.
James Andrews, MD, of Andrews Institute for Orthopaedics & Sports Medicine in Gulf Breeze, Fla., will perform exploratory shoulder surgery on Toronto Blue Jays pitcher Dustin McGowan, according to an MLB report.
The U.S. Attorney's Office for the Western District of Tennessee issued a subpoena for all documents related to Wright Medical Group's Profemur line of hip devices, according to a Wall Street Journal report.
GHX today announced successful results from its initial implantable device supply chain pilot sites.
Alphatec Spine has announced second quarter net revenues of $48.2 million, a 5.2 percent decrease compared to the same quarter last year.
Alphatec Holdings, parent company of Alphatec Spine, has appointed Luke T. Faulstick to the company's board of directors.
The Center for Regenerative Medicine in Miami is now treating chondromalacia patella, cartilage damage that causes anterior knee pain, according to a PRWeb release.
Jeffrey Garrett, MD, will be joining the staff of North Fulton Hospital in Roswell, Ga., as an orthopedic traumatologist, according to Patch.com.